20-17950344-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014426.4(SNX5):āc.662A>Gā(p.Asn221Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX5 | NM_014426.4 | c.662A>G | p.Asn221Ser | missense_variant | 7/13 | ENST00000377759.9 | NP_055241.1 | |
SNX5 | NM_152227.3 | c.662A>G | p.Asn221Ser | missense_variant | 8/14 | NP_689413.1 | ||
SNX5 | NM_001282454.2 | c.347A>G | p.Asn116Ser | missense_variant | 7/13 | NP_001269383.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251100Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135758
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461366Hom.: 0 Cov.: 29 AF XY: 0.0000179 AC XY: 13AN XY: 727004
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.662A>G (p.N221S) alteration is located in exon 8 (coding exon 7) of the SNX5 gene. This alteration results from a A to G substitution at nucleotide position 662, causing the asparagine (N) at amino acid position 221 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at